Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
139.18
-2.42 (-1.71%)
At close: Mar 25, 2025, 4:00 PM
140.38
+1.20 (0.86%)
After-hours: Mar 25, 2025, 4:38 PM EST
Biogen Stock Forecast
Stock Price Forecast
The 24 analysts with 12-month price forecasts for Biogen stock have an average target of 220.5, with a low estimate of 135 and a high estimate of 342. The average target predicts an increase of 58.43% from the current stock price of 139.18.
Analyst Consensus: Buy
* Price targets were last updated on Feb 18, 2025.
Analyst Ratings
The average analyst rating for Biogen stock from 27 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 6 | 6 | 7 | 7 |
| Buy | 8 | 8 | 7 | 6 | 6 | 6 |
| Hold | 8 | 10 | 13 | 14 | 14 | 14 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 25 | 26 | 26 | 27 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $138 → $135 | Hold | Reiterates | $138 → $135 | -3.00% | Feb 18, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $244 → $224 | Buy | Maintains | $244 → $224 | +60.94% | Feb 13, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $156 → $139 | Hold | Maintains | $156 → $139 | -0.13% | Feb 13, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $192 → $157 | Hold | Maintains | $192 → $157 | +12.80% | Feb 13, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $281 → $245 | Strong Buy | Maintains | $281 → $245 | +76.03% | Feb 13, 2025 |
Financial Forecast
Revenue This Year
9.38B
from 9.68B
Decreased by -3.06%
Revenue Next Year
9.33B
from 9.38B
Decreased by -0.49%
EPS This Year
16.17
from 11.18
Increased by 44.60%
EPS Next Year
16.13
from 16.17
Decreased by -0.21%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.4B | 10.8B | 12.0B | ||
| Avg | 9.4B | 9.3B | 9.6B | ||
| Low | 8.8B | 8.4B | 8.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.7% | 15.6% | 29.0% | ||
| Avg | -3.1% | -0.5% | 2.6% | ||
| Low | -9.1% | -10.1% | -7.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.15 | 21.68 | 26.79 | ||
| Avg | 16.17 | 16.13 | 17.46 | ||
| Low | 13.44 | 11.78 | 13.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 89.2% | 34.1% | 66.0% | ||
| Avg | 44.6% | -0.2% | 8.2% | ||
| Low | 20.2% | -27.1% | -18.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.